Yoga-based Group Therapy for In-patients With Schizophrenia Spectrum Disorders — YING  

Psychotic Disorders Clinical Trial

Official title: Yoga-based Group Therapy for In-Patients With Schizophrenia Spectrum Disorder - Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial

Status Recruiting

Clinical Trial Summary

A rater-blinded randomized controlled trial with a parallel-group design is utilized, comprised of yoga-based group therapy (YBGT) in the experimental condition, and treatment as usual (TAU) in the control condition. The participants in the experimental condition participate in YBGT beside their regular psychiatric treatment (TAU). The intervention is designed for in-patients with schizophrenia spectrum disorders. With the aim of examining the feasibility, acceptability and effectiveness, self-report and blinded rater-based assessments are evaluated before the YBGT (T0), and after four weeks of taking part in intervention (T1).

Clinical Trial Description

Psychiatrists and psychologists at the ward for psychotic disorders identify eligible participants and invite them to participate in the study. An eligibility screening is held by the study assistant at baseline, introducing the study, providing informed electronic consent, as well as conducting the self-report measures and app-based assessments. A blinded psychologist who works independently of the (co-) psychologist conducts the remaining rater-questionnaires. Due to the psychotherapeutic nature of the study, information about the treatment allocation had to be shared with the co-psychologist and the participants. Saliva samples are also taken to examine stress-related biomarkers. Randomization was conducted by the Random Group Generator (pubmed, 2018). The data management plan includes standard procedures for data-handling such as using anonymized identification codes for patient data. The participants have the right to access their data, and the right to claim an annihilation. The data is being saved in an online database, only allowing researchers involved in the study to access the data. ;

Related Conditions & MeSH terms

• Mental Disorders
• Psychotic Disorders
• Schizophrenia

• NCT number: NCT04730518
• Study type: Interventional
• Source: Charite University, Berlin, Germany
• Contact: Kerem Böge, Dr.
• Phone: 0049 30 450 517 789
• Email: Kerem.boege@charite.de
• Status: Recruiting
• Phase: N/A
• Start date: January 28, 2021
• Completion date: December 30, 2023